×
It looks like you're using an obsolete version of internet explorer. Internet explorer is no longer supported by Microsoft since the end of 2015. We invite you to use a newer browser such as Firefox, Google Chrome or Microsoft Edge.
0
Days
0
Hours
0
Minutes
0
Seconds


Wednesday, January 22nd 2025
06pm to 07:30pm (GMT+1)

Become an Oncostream member and receive full access to its content!

You must be an Oncostream member to access videos without any restrictions. Register for free in one minute and access all services provided by Oncostream.You will also be able to log into Oncostream from your Facebook or twitter account by clicking on login on the top-right corner of Oncostream website.

Registration Login


Worldwide schedules comment Share
Add to calendar Notify me
 Browser notifications are enabled

Modératrice :
Isabelle Ray-Coquard

Intervenants :
Florence Joly
Olivia Le Saux
Stanislas Quesada

Agenda

18:00 Caractérisation et définition de la rechute et de la résistance aux sels de platine
Olivia Le Saux
 
18:20 Stratégie thérapeutique actuelle et à venir (incluant les nouveaux biomarqueurs dans les cancers de l'ovaire en rechute)
Stanislas Quesada
 
18:40 Quelles spécificités du parcours de soins des cancers résistants aux sels de platine
Florence Joly
 
19:00 Débat/Discussion – Réponses aux questions
 

 

Shooting date : 2025-01-22
Last update : 2025-01-20

Suggestions

Wednesday, November 16th 2022 from 06pm to 07:30pm (GMT+1)
Honolulu : Wednesday, November 16th 2022 from 07am to 08:30am (GMT+1)
San Francisco : Wednesday, November 16th 2022 from 09am to 10:30am (GMT+1)
New York : Wednesday, November 16th 2022 from 12pm to 01:30pm (GMT+1)
Buenos Aires : Wednesday, November 16th 2022 from 02pm to 03:30pm (GMT+1)
London / Dublin : Wednesday, November 16th 2022 from 05pm to 06:30pm (GMT+1)
Paris / Berlin : Wednesday, November 16th 2022 from 06pm to 07:30pm (GMT+1)
Istanbul : Wednesday, November 16th 2022 from 07pm to 08:30pm (GMT+1)
Moscou / Dubaï : Wednesday, November 16th 2022 from 09pm to 10:30pm (GMT+1)
Bangkok : Thursday, November 17th 2022 from 12am to 01:30am (GMT+1)
Shanghai : Thursday, November 17th 2022 from 01am to 02:30am (GMT+1)
Tokyo : Thursday, November 17th 2022 from 02am to 03:30am (GMT+1)
Sydney : Thursday, November 17th 2022 from 03am to 04:30am (GMT+1)
Wellington : Thursday, November 17th 2022 from 05am to 06:30am (GMT+1)

Cancer de l’ovaire et iPARP

Share
Tuesday, January 31st 2023 from 06pm to 07:30pm (GMT+1)
Honolulu : Tuesday, January 31st 2023 from 07am to 08:30am (GMT+1)
San Francisco : Tuesday, January 31st 2023 from 09am to 10:30am (GMT+1)
New York : Tuesday, January 31st 2023 from 12pm to 01:30pm (GMT+1)
Buenos Aires : Tuesday, January 31st 2023 from 02pm to 03:30pm (GMT+1)
London / Dublin : Tuesday, January 31st 2023 from 05pm to 06:30pm (GMT+1)
Paris / Berlin : Tuesday, January 31st 2023 from 06pm to 07:30pm (GMT+1)
Istanbul : Tuesday, January 31st 2023 from 07pm to 08:30pm (GMT+1)
Moscou / Dubaï : Tuesday, January 31st 2023 from 09pm to 10:30pm (GMT+1)
Bangkok : Wednesday, February 1st 2023 from 12am to 01:30am (GMT+1)
Shanghai : Wednesday, February 1st 2023 from 01am to 02:30am (GMT+1)
Tokyo : Wednesday, February 1st 2023 from 02am to 03:30am (GMT+1)
Sydney : Wednesday, February 1st 2023 from 03am to 04:30am (GMT+1)
Wellington : Wednesday, February 1st 2023 from 05am to 06:30am (GMT+1)

Cancer de l'ovaire en 1L :

Actualités et options thérapeutiques disponibles en 2023

Share
Tuesday, November 21st 2023 from 06pm to 07:30pm (GMT+1)
Honolulu : Tuesday, November 21st 2023 from 07am to 08:30am (GMT+1)
San Francisco : Tuesday, November 21st 2023 from 09am to 10:30am (GMT+1)
New York : Tuesday, November 21st 2023 from 12pm to 01:30pm (GMT+1)
Buenos Aires : Tuesday, November 21st 2023 from 02pm to 03:30pm (GMT+1)
London / Dublin : Tuesday, November 21st 2023 from 05pm to 06:30pm (GMT+1)
Paris / Berlin : Tuesday, November 21st 2023 from 06pm to 07:30pm (GMT+1)
Istanbul : Tuesday, November 21st 2023 from 07pm to 08:30pm (GMT+1)
Moscou / Dubaï : Tuesday, November 21st 2023 from 09pm to 10:30pm (GMT+1)
Bangkok : Wednesday, November 22nd 2023 from 12am to 01:30am (GMT+1)
Shanghai : Wednesday, November 22nd 2023 from 01am to 02:30am (GMT+1)
Tokyo : Wednesday, November 22nd 2023 from 02am to 03:30am (GMT+1)
Sydney : Wednesday, November 22nd 2023 from 03am to 04:30am (GMT+1)
Wellington : Wednesday, November 22nd 2023 from 05am to 06:30am (GMT+1)

Cancer de l'ovaire : comment évaluer aujourd'hui la recombinaison homologue ?

Share
Thursday, March 14th 2024 from 06pm to 07:30pm (GMT+1)
Honolulu : Thursday, March 14th 2024 from 07am to 08:30am (GMT+1)
San Francisco : Thursday, March 14th 2024 from 09am to 10:30am (GMT+1)
New York : Thursday, March 14th 2024 from 12pm to 01:30pm (GMT+1)
Buenos Aires : Thursday, March 14th 2024 from 02pm to 03:30pm (GMT+1)
London / Dublin : Thursday, March 14th 2024 from 05pm to 06:30pm (GMT+1)
Paris / Berlin : Thursday, March 14th 2024 from 06pm to 07:30pm (GMT+1)
Istanbul : Thursday, March 14th 2024 from 07pm to 08:30pm (GMT+1)
Moscou / Dubaï : Thursday, March 14th 2024 from 09pm to 10:30pm (GMT+1)
Bangkok : Friday, March 15th 2024 from 12am to 01:30am (GMT+1)
Shanghai : Friday, March 15th 2024 from 01am to 02:30am (GMT+1)
Tokyo : Friday, March 15th 2024 from 02am to 03:30am (GMT+1)
Sydney : Friday, March 15th 2024 from 03am to 04:30am (GMT+1)
Wellington : Friday, March 15th 2024 from 05am to 06:30am (GMT+1)

Prise en charge du cancer de l’ovaire en L1 en région Nord/Normandie : où en sommes-nous ?

Cycle d'enseignement sur le cancer de l'ovaire - Troisième session

Share
Scroll Up